Open States

  1. Introduced Jan 30, 2017
  2. Passed House Mar 20, 2017
  3. Passed Senate Apr 7, 2017
  4. Signed into Law

HB 631

Maryland House Bill

Public Health - Essential Off-Patent or Generic Drugs - Price Gouging - Prohibition
Session:
2017 Regular Session
Bill Subjects:
Legal Issues Drugs Judiciary Executive Branch Other Federal, State, and Local Relations Technology and Communication Health Business and Consumers
Sponsors (89):

Votes

Actions

Date Chamber  
May 27, 2017 Executive Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 818
Apr 10, 2017 House Passed Enrolled
Apr 10, 2017 House Third Reading Passed (137-2) - Related Vote
Apr 10, 2017 House House Concur - Senate Amendments
Apr 7, 2017 Senate Third Reading Passed with Amendments (38-7)
Apr 7, 2017 Senate Floor Amendment {893327/1 (Senator Hershey) Rejected (14-31)
Apr 7, 2017 Senate Floor Amendment {683326/1 (Senator Hershey) Rejected (13-32)
Apr 6, 2017 Senate Second Reading Passed with Amendments
Apr 6, 2017 Senate Floor Amendment {943322/2 (Senator Jennings) Adopted
Apr 5, 2017 Senate Special Order until 4/6 (Senator Feldman) Adopted
Apr 5, 2017 Senate Favorable with Amendments {247274/1 Report Adopted
Apr 5, 2017 Senate Favorable with Amendments Report by Finance
Mar 22, 2017 Senate Hearing 3/23 at 1:00 p.m.
Mar 21, 2017 Senate First Reading Finance
Mar 20, 2017 House Third Reading Passed (137-4)
Mar 20, 2017 House Second Reading Passed with Amendments
Mar 20, 2017 House Favorable with Amendments {376789/1 Report Adopted
Mar 20, 2017 House Favorable with Amendments Report by Health and Government Operations
Feb 8, 2017 House Hearing 2/23 at 1:00 p.m. (Health and Government Operations)
Jan 30, 2017 House First Reading Health and Government Operations and Economic Matters

Bill Text

Sources

Data on Open States is automatically collected nightly from the official website of the Maryland General Assembly. If you notice any errors, feel free to contact us or verify that the data matches the official sources below.